1. Home
  2. ACR vs ACET Comparison

ACR vs ACET Comparison

Compare ACR & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACR
  • ACET
  • Stock Information
  • Founded
  • ACR 2005
  • ACET 1947
  • Country
  • ACR United States
  • ACET United States
  • Employees
  • ACR N/A
  • ACET N/A
  • Industry
  • ACR Real Estate Investment Trusts
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACR Real Estate
  • ACET Health Care
  • Exchange
  • ACR Nasdaq
  • ACET Nasdaq
  • Market Cap
  • ACR 136.9M
  • ACET 93.1M
  • IPO Year
  • ACR N/A
  • ACET N/A
  • Fundamental
  • Price
  • ACR $15.94
  • ACET $0.91
  • Analyst Decision
  • ACR Buy
  • ACET Strong Buy
  • Analyst Count
  • ACR 2
  • ACET 4
  • Target Price
  • ACR $17.50
  • ACET $5.67
  • AVG Volume (30 Days)
  • ACR 14.4K
  • ACET 771.3K
  • Earning Date
  • ACR 10-30-2024
  • ACET 11-06-2024
  • Dividend Yield
  • ACR N/A
  • ACET N/A
  • EPS Growth
  • ACR N/A
  • ACET N/A
  • EPS
  • ACR 0.83
  • ACET N/A
  • Revenue
  • ACR $77,437,000.00
  • ACET N/A
  • Revenue This Year
  • ACR N/A
  • ACET N/A
  • Revenue Next Year
  • ACR N/A
  • ACET N/A
  • P/E Ratio
  • ACR $19.18
  • ACET N/A
  • Revenue Growth
  • ACR 8.77
  • ACET N/A
  • 52 Week Low
  • ACR $9.41
  • ACET $0.81
  • 52 Week High
  • ACR $17.77
  • ACET $3.77
  • Technical
  • Relative Strength Index (RSI)
  • ACR 39.10
  • ACET 37.30
  • Support Level
  • ACR $14.94
  • ACET $0.81
  • Resistance Level
  • ACR $17.31
  • ACET $0.98
  • Average True Range (ATR)
  • ACR 0.40
  • ACET 0.08
  • MACD
  • ACR -0.25
  • ACET -0.00
  • Stochastic Oscillator
  • ACR 35.34
  • ACET 31.25

About ACR ACRES Commercial Realty Corp.

ACRES Commercial Realty Corp is a commercial real estate investment trust that focuses on originating, holding and managing commercial real estate (CRE) mortgage loans and equity investments in commercial real estate properties through direct ownership and joint ventures. The company invests in commercial real-estate-related assets, including whole loans, A notes, B notes, mezzanine loans, and mortgage-related securities, as well as commercial finance assets, which include other asset-backed securities, senior secured corporate loans, equipment leases and notes, trust preferred securities, debt tranches of collateralize debt obligations, and private equity investments mainly issued by financial institutions.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: